FDA Approves First Pre-Surgical Breast Cancer Drug

Published October 21, 2013

FDA approves first pre-surgical breast cancer drug
The FDA granted the drug accelerated approval for its new use based on a study showing women who received the drug as an initial treatment were more likely to be cancer-free 12 weeks later than women who received older drug combinations. … Genentech …
Read more on U-T San Diego

Protalix BioTherapeutics Announces Positive Phase I Clinical Trial Results for …
Oral GCD is an orally available form of the plant cell-expressed enzyme, glucocerebrosidase or GCD, which is the same active substance as the Company's approved enzyme replacement therapy, ELELYSO(TM). Oral GCD … The study is being conducted in two …
Read more on Wall Street Journal

ACADIA Pharmaceuticals Inc. (ACAD): Acadia And Parkinson's Treatment Hopes
Acadia Pharmaceuticals (ACAD), a small firm based in San Diego, Ca is developing pimavanserin, a promising new drug for PDP (Parkinson's Disease Psychosis). Psychosis is a disabling nonmotor complication of the Parkinson's disease. Visual …
Read more on Seeking Alpha